Literature DB >> 31935283

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Zhaohui Du1, Niels Weinhold2, Gregory Chi Song3, Kristin A Rand3, David J Van Den Berg1, Amie E Hwang3, Xin Sheng1, Victor Hom3, Sikander Ailawadhi4, Ajay K Nooka5, Seema Singhal6, Karen Pawlish7, Edward S Peters8, Cathryn Bock9, Ann Mohrbacher10, Alexander Stram3, Sonja I Berndt11, William J Blot12, Graham Casey13, Victoria L Stevens14, Rick Kittles15, Phyllis J Goodman16, W Ryan Diver14, Anselm Hennis17, Barbara Nemesure17, Eric A Klein18, Benjamin A Rybicki19, Janet L Stanford20, John S Witte21, Lisa Signorello11, Esther M John22, Leslie Bernstein15, Antoinette M Stroup7,23, Owen W Stephens2, Maurizio Zangari2, Frits Van Rhee2, Andrew Olshan24, Wei Zheng12, Jennifer J Hu25, Regina Ziegler11, Sarah J Nyante26, Sue Ann Ingles3, Michael F Press27, John David Carpten28, Stephen J Chanock11, Jayesh Mehta6, Graham A Colditz29, Jeffrey Wolf21, Thomas G Martin21, Michael Tomasson30, Mark A Fiala29, Howard Terebelo31, Nalini Janakiraman32, Laurence Kolonel33, Kenneth C Anderson34, Loic Le Marchand33, Daniel Auclair35, Brian C-H Chiu36, Elad Ziv21, Daniel Stram3, Ravi Vij29, Leon Bernal-Mizrachi37, Gareth J Morgan38, Jeffrey A Zonder9, Carol Ann Huff39, Sagar Lonial5, Robert Z Orlowski40, David V Conti1, Christopher A Haiman1, Wendy Cozen1,27.   

Abstract

Persons of African ancestry (AA) have a twofold higher risk for multiple myeloma (MM) compared with persons of European ancestry (EA). Genome-wide association studies (GWASs) support a genetic contribution to MM etiology in individuals of EA. Little is known about genetic risk factors for MM in individuals of AA. We performed a meta-analysis of 2 GWASs of MM in 1813 cases and 8871 controls and conducted an admixture mapping scan to identify risk alleles. We fine-mapped the 23 known susceptibility loci to find markers that could better capture MM risk in individuals of AA and constructed a polygenic risk score (PRS) to assess the aggregated effect of known MM risk alleles. In GWAS meta-analysis, we identified 2 suggestive novel loci located at 9p24.3 and 9p13.1 at P < 1 × 10-6; however, no genome-wide significant association was noted. In admixture mapping, we observed a genome-wide significant inverse association between local AA at 2p24.1-23.1 and MM risk in AA individuals. Of the 23 known EA risk variants, 20 showed directional consistency, and 9 replicated at P < .05 in AA individuals. In 8 regions, we identified markers that better capture MM risk in persons with AA. AA individuals with a PRS in the top 10% had a 1.82-fold (95% confidence interval, 1.56-2.11) increased MM risk compared with those with average risk (25%-75%). The strongest functional association was between the risk allele for variant rs56219066 at 5q15 and lower ELL2 expression (P = 5.1 × 10-12). Our study shows that common genetic variation contributes to MM risk in individuals with AA.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31935283      PMCID: PMC6960456          DOI: 10.1182/bloodadvances.2019000491

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  38 in total

1.  KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.

Authors:  S Medves; F P Duhoux; A Ferrant; F Toffalini; G Ameye; J-M Libouton; H A Poirel; J-B Demoulin
Journal:  Leukemia       Date:  2010-02-18       Impact factor: 11.528

2.  The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.

Authors:  Niels Weinhold; Tobias Meissner; David C Johnson; Anja Seckinger; Jérôme Moreaux; Asta Försti; Bowang Chen; Jolanta Nickel; Daniel Chubb; Andrew C Rawstron; Chi Doughty; Nasrin B Dahir; Dil B Begum; Kwee Young; Brian A Walker; Per Hoffmann; Marcus M Nöthen; Faith E Davies; Bernard Klein; Hartmut Goldschmidt; Gareth J Morgan; Richard S Houlston; Dirk Hose; Kari Hemminki
Journal:  Haematologica       Date:  2014-12-05       Impact factor: 9.941

3.  Next-generation genotype imputation service and methods.

Authors:  Sayantan Das; Lukas Forer; Sebastian Schönherr; Carlo Sidore; Adam E Locke; Alan Kwong; Scott I Vrieze; Emily Y Chew; Shawn Levy; Matt McGue; David Schlessinger; Dwight Stambolian; Po-Ru Loh; William G Iacono; Anand Swaroop; Laura J Scott; Francesco Cucca; Florian Kronenberg; Michael Boehnke; Gonçalo R Abecasis; Christian Fuchsberger
Journal:  Nat Genet       Date:  2016-08-29       Impact factor: 38.330

4.  Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.

Authors:  Brenda M Birmann; Marian L Neuhouser; Bernard Rosner; Demetrius Albanes; Julie E Buring; Graham G Giles; Qing Lan; I-Min Lee; Mark P Purdue; Nathaniel Rothman; Gianluca Severi; Jian-Min Yuan; Kenneth C Anderson; Michael Pollak; Nader Rifai; Patricia Hartge; Ola Landgren; Lawrence Lessin; Jarmo Virtamo; Robert B Wallace; JoAnn E Manson; Graham A Colditz
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

5.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.

Authors:  Daniel Chubb; Niels Weinhold; Peter Broderick; Bowang Chen; David C Johnson; Asta Försti; Jayaram Vijayakrishnan; Gabriele Migliorini; Sara E Dobbins; Amy Holroyd; Dirk Hose; Brian A Walker; Faith E Davies; Walter A Gregory; Graham H Jackson; Julie A Irving; Guy Pratt; Chris Fegan; James Al Fenton; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Christian Straka; Hermann Einsele; Christian Langer; Elisabeth Dörner; James M Allan; Anna Jauch; Gareth J Morgan; Kari Hemminki; Richard S Houlston; Hartmut Goldschmidt
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

6.  Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.

Authors:  Peter Broderick; Daniel Chubb; David C Johnson; Niels Weinhold; Asta Försti; Amy Lloyd; Bianca Olver; Yussanne Ma; Sara E Dobbins; Brian A Walker; Faith E Davies; Walter A Gregory; J Anthony Childs; Fiona M Ross; Graham H Jackson; Kai Neben; Anna Jauch; Per Hoffmann; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Ian P Tomlinson; Hartmut Goldschmidt; Kari Hemminki; Gareth J Morgan; Richard S Houlston
Journal:  Nat Genet       Date:  2011-11-27       Impact factor: 38.330

7.  Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.

Authors:  Philip J Law; Amit Sud; Jonathan S Mitchell; Marc Henrion; Giulia Orlando; Oleg Lenive; Peter Broderick; Helen E Speedy; David C Johnson; Martin Kaiser; Niels Weinhold; Rosie Cooke; Nicola J Sunter; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; David J Allsup; Jonathan Carmichael; James R Bailey; Guy Pratt; Thahira Rahman; Chris Pepper; Chris Fegan; Elke Pogge von Strandmann; Andreas Engert; Asta Försti; Bowang Chen; Miguel Inacio da Silva Filho; Hauke Thomsen; Per Hoffmann; Markus M Noethen; Lewin Eisele; Karl-Heinz Jöckel; James M Allan; Anthony J Swerdlow; Hartmut Goldschmidt; Daniel Catovsky; Gareth J Morgan; Kari Hemminki; Richard S Houlston
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

8.  The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression.

Authors:  Mina Ali; Ram Ajore; Anna-Karin Wihlborg; Abhishek Niroula; Bhairavi Swaminathan; Ellinor Johnsson; Owen W Stephens; Gareth Morgan; Tobias Meissner; Ingemar Turesson; Hartmut Goldschmidt; Ulf-Henrik Mellqvist; Urban Gullberg; Markus Hansson; Kari Hemminki; Hareth Nahi; Anders Waage; Niels Weinhold; Björn Nilsson
Journal:  Nat Commun       Date:  2018-04-25       Impact factor: 14.919

9.  Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.

Authors:  Paul Smith; Linda J Nicholson; Nelofer Syed; Annette Payne; Louise Hiller; Ornella Garrone; Marcella Occelli; Milena Gasco; Tim Crook
Journal:  Clin Cancer Res       Date:  2007-07-15       Impact factor: 12.531

10.  An overview of STRUCTURE: applications, parameter settings, and supporting software.

Authors:  Liliana Porras-Hurtado; Yarimar Ruiz; Carla Santos; Christopher Phillips; Angel Carracedo; Maria V Lareu
Journal:  Front Genet       Date:  2013-05-29       Impact factor: 4.599

View more
  6 in total

1.  How researchers are addressing the racial imbalance in multiple myeloma.

Authors:  Cassandra Willyard
Journal:  Nature       Date:  2020-11       Impact factor: 49.962

Review 2.  Recent innovations and in-depth aspects of post-genome wide association study (Post-GWAS) to understand the genetic basis of complex phenotypes.

Authors:  Zahra Mortezaei; Mahmood Tavallaei
Journal:  Heredity (Edinb)       Date:  2021-10-23       Impact factor: 3.821

3.  Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans.

Authors:  Andrew Staron; Luke Zheng; Gheorghe Doros; Vaishali Sanchorawala
Journal:  Blood Cancer J       Date:  2022-07-04       Impact factor: 9.812

4.  Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program.

Authors:  Yao Hu; Adrienne M Stilp; Caitlin P McHugh; Shuquan Rao; Deepti Jain; Xiuwen Zheng; John Lane; Sébastian Méric de Bellefon; Laura M Raffield; Ming-Huei Chen; Lisa R Yanek; Marsha Wheeler; Yao Yao; Chunyan Ren; Jai Broome; Jee-Young Moon; Paul S de Vries; Brian D Hobbs; Quan Sun; Praveen Surendran; Jennifer A Brody; Thomas W Blackwell; Hélène Choquet; Kathleen Ryan; Ravindranath Duggirala; Nancy Heard-Costa; Zhe Wang; Nathalie Chami; Michael H Preuss; Nancy Min; Lynette Ekunwe; Leslie A Lange; Mary Cushman; Nauder Faraday; Joanne E Curran; Laura Almasy; Kousik Kundu; Albert V Smith; Stacey Gabriel; Jerome I Rotter; Myriam Fornage; Donald M Lloyd-Jones; Ramachandran S Vasan; Nicholas L Smith; Kari E North; Eric Boerwinkle; Lewis C Becker; Joshua P Lewis; Goncalo R Abecasis; Lifang Hou; Jeffrey R O'Connell; Alanna C Morrison; Terri H Beaty; Robert Kaplan; Adolfo Correa; John Blangero; Eric Jorgenson; Bruce M Psaty; Charles Kooperberg; Russell T Walton; Benjamin P Kleinstiver; Hua Tang; Ruth J F Loos; Nicole Soranzo; Adam S Butterworth; Debbie Nickerson; Stephen S Rich; Braxton D Mitchell; Andrew D Johnson; Paul L Auer; Yun Li; Rasika A Mathias; Guillaume Lettre; Nathan Pankratz; Cathy C Laurie; Cecelia A Laurie; Daniel E Bauer; Matthew P Conomos; Alexander P Reiner
Journal:  Am J Hum Genet       Date:  2021-04-21       Impact factor: 11.025

5.  Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease.

Authors:  Hari K Somineni; Sini Nagpal; Suresh Venkateswaran; David J Cutler; David T Okou; Talin Haritunians; Claire L Simpson; Ferdouse Begum; Lisa W Datta; Antonio J Quiros; Jenifer Seminerio; Emebet Mengesha; Jonathan S Alexander; Robert N Baldassano; Sharon Dudley-Brown; Raymond K Cross; Themistocles Dassopoulos; Lee A Denson; Tanvi A Dhere; Heba Iskandar; Gerald W Dryden; Jason K Hou; Sunny Z Hussain; Jeffrey S Hyams; Kim L Isaacs; Howard Kader; Michael D Kappelman; Jeffry Katz; Richard Kellermayer; John F Kuemmerle; Mark Lazarev; Ellen Li; Peter Mannon; Dedrick E Moulton; Rodney D Newberry; Ashish S Patel; Joel Pekow; Shehzad A Saeed; John F Valentine; Ming-Hsi Wang; Jacob L McCauley; Maria T Abreu; Traci Jester; Zarela Molle-Rios; Sirish Palle; Ellen J Scherl; John Kwon; John D Rioux; Richard H Duerr; Mark S Silverberg; Michael E Zwick; Christine Stevens; Mark J Daly; Judy H Cho; Greg Gibson; Dermot P B McGovern; Steven R Brant; Subra Kugathasan
Journal:  Am J Hum Genet       Date:  2021-02-17       Impact factor: 11.025

6.  A polygenic risk score for multiple myeloma risk prediction.

Authors:  Federico Canzian; Chiara Piredda; Angelica Macauda; Daria Zawirska; Niels Frost Andersen; Arnon Nagler; Jan Maciej Zaucha; Grzegorz Mazur; Charles Dumontet; Marzena Wątek; Krzysztof Jamroziak; Juan Sainz; Judit Várkonyi; Aleksandra Butrym; Katia Beider; Niels Abildgaard; Fabienne Lesueur; Marek Dudziński; Annette Juul Vangsted; Matteo Pelosini; Edyta Subocz; Mario Petrini; Gabriele Buda; Małgorzata Raźny; Federica Gemignani; Herlander Marques; Enrico Orciuolo; Katalin Kadar; Artur Jurczyszyn; Agnieszka Druzd-Sitek; Ulla Vogel; Vibeke Andersen; Rui Manuel Reis; Anna Suska; Hervé Avet-Loiseau; Marcin Kruszewski; Waldemar Tomczak; Marcin Rymko; Stephane Minvielle; Daniele Campa
Journal:  Eur J Hum Genet       Date:  2021-11-30       Impact factor: 4.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.